ArticleTranslational psychiatry2026
Surveying alternative transcripts of disease-associated genes and their cell type specificity - a case study with ANK3.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ANK3 gene has been conclusively linked to bipolar disorder, but its role in disease etiology remains unclear: both the specific transcript and its expressing cell type remain unclear. This is a near-universal problem for genes associated with polygenic neuropsychiatric disorders. One of the causes of this unfortunate stasis is that human transcript databases have an incomplete list of alternative isoforms of genes and that it is technically challenging to identify the cell-types in which they are expressed. Here, we address this knowledge gap for ANK3. ANK3 is a useful case study because of its rich alternative splicing and important neurobiological role in neurons and oligodendrocytes. We used Oxford nanopore sequencing of full-length transcripts to identify all human and mouse ANK3 exons. Then, we isolate and sort brain nuclei and use droplet-digital PCR to measure cell-type specific expression of alternatively spliced exons. We confirm that RefSeq transcript annotations of ANK3 lack many of the alternatively spliced exons and we show that, despite being lowly expressed, these exons are highly evolutionarily conserved and have strong cell type specificity. Elucidating psychiatric disorder etiology will require an overview of the transcripts of all the disorder-associated genes and the cell types in which these transcripts are expressed. This work on ANK3 illustrates the extent to which such information is currently lacking, ways in which the information can be acquired, and the technical challenges that are encountered in the process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.